Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Iqra A. Syed"'
Autor:
Dylan E. O’Sullivan, Winson Y. Cheung, Iqra A. Syed, Daniel Moldaver, Mary Kate Shanahan, D. Gwyn Bebb, Christina Sit, Darren R. Brenner, Devon J. Boyne
Publikováno v:
Current Oncology, Vol 28, Iss 4, Pp 3091-3103 (2021)
The prognosis for extensive-stage small cell lung cancer (ES-SCLC) is poor. Real-world evidence can highlight the unmet clinical need within this population. We conducted a population-based cohort study of ES-SCLC patients diagnosed in a large Canadi
Externí odkaz:
https://doaj.org/article/6f3061a84340489da0e3d7b1de11619b
Autor:
Dylan E. O'Sullivan, Devon J. Boyne, Iqra A. Syed, Cal S. Shephard, Derek L. Clouthier, Eric M. Yoshida, Jennifer L. Spratlin, Atul Batra, Rodrigo Rigo, Malek Hannouf, Xun Yang Hu, Tamer N. Jarada, Darren Brenner, Winson Y. Cheung
Publikováno v:
Canadian Liver Journal.
400 Background: The incidence of advanced unresectable hepatocellular carcinoma (HCC) is increasing in several developed countries and the prognosis of advanced HCC remains poor. Real-world evidence of treatment patterns and patient outcomes can high
Publikováno v:
Journal of Clinical Oncology. 40:e16538-e16538
e16538 Background: Prior single institutional studies and case series suggest that management of urothelial carcinoma of the bladder (UCB) can be highly variable across different centers. To better contextualize emerging therapies and their place in
Autor:
Juliette Thompson, Sonal Singh, Maria B. Yu, Ellen E. Korol, Rattan Juneja, Iqra A. Syed, Nathalie Waser, Eugene E. Wright, Anita Y. M. Kwan
Publikováno v:
Diabetes, Obesity & Metabolism
Aims Since 2005, several glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been approved to treat people with type 2 diabetes. These agents are considered for use at the same point in the treatment paradigm as basal insulins. A comprehensive